BioTime, Inc. Share Price Nyse
Equities
US09066L1052
Biotechnology & Medical Research
Sales 2024 * | 12.22M 1.02B | Sales 2025 * | 5.87M 490M | Capitalization | 200M 16.71B |
---|---|---|---|---|---|
Net income 2024 * | -24M -2B | Net income 2025 * | -35M -2.92B | EV / Sales 2024 * | 16.4 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 34.1 x |
P/E ratio 2024 * |
-8.15
x | P/E ratio 2025 * |
-6.16
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.57% |
Latest transcript on BioTime, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 17/18/17 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 14/22/14 |
Chief Operating Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 01/09/01 |
Brian Culley
CEO | Chief Executive Officer | 53 | 17/18/17 |
Director/Board Member | 66 | 11/14/11 |
1st Jan change | Capi. | |
---|---|---|
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |